Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-18-043810
Filing Date
2018-07-24
Accepted
2018-07-24 19:07:04
Documents
2
Period of Report
2018-07-23

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2166
2 POA DOCUMENT poa.txt EX-24.3_802529 3669
  Complete submission text file 0001209191-18-043810.txt   7160
Mailing Address C/O QUEST DIAGNOSTICS 500 PLAZA DRIVE SECAUCUS NJ 07094
Business Address
GUINAN MARK (Reporting) CIK: 0001505998 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37929 | Film No.: 18967361

Mailing Address 20-22 BEDFORD ROW LONDON X0 WC1R 4JS
Business Address 20-22 BEDFORD ROW LONDON X0 WC1R 4JS (441) 824-8101
Myovant Sciences Ltd. (Issuer) CIK: 0001679082 (see all company filings)

EIN.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations